- Category
- Micro (2021-22)
- Udyam number
- UDYAM-GJ-01-0113228

Morbus Medicines Private Limited
About Morbus Medicines Private Limited
Data last updated:
Morbus Medicines Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2021PTC125976.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Saurabh Hareshbhai Aacharya and Saumin Prakashbhai Shah.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 311 Avani Icon Haridarshan Cross Road Naroda, Ahmedabad, Gujarat, India – 382330.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.15 Lakh, a decline of 69% compared to the previous year. For the same year it recorded a net loss of ₹39,986 (net margin -4.9%) and EBITDA of -₹29,085 (EBITDA margin -3.6%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
Morbus Medicines Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0113228).
Company details
Recognitions & Rankings of Morbus Medicines
Contact details
Morbus Medicines Private Limited's registered office is in Ahmedabad, Gujarat.
- Registered AddressShop No 311 Avani Icon Haridarshan Cross Road Naroda, Ahmedabad, Gujarat, India – 382330
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Morbus Medicines is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Morbus Medicines Private Limited, buy the company report.
Financials of Morbus Medicines Private Limited
FY 2025 filings availableMorbus Medicines Private Limited reported revenue of ₹8.15 Lakh (down 69% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 69% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹29,085 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹39,986 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -3.6% | |||
| Net Profit Margin | -4.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Morbus Medicines Private Limited, buy the company report.
Board of directors of Morbus Medicines Private Limited
Morbus Medicines has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Hareshbhai Aacharya | Director | 29 Sep 2021 | 5 Years 1 Months | Current |
| Saumin Prakashbhai Shah Also directs: Gujarat Gastro LLP | Director | 29 Sep 2021 | 5 Years 1 Months | Current |
| Yogesh Purshottam Harwani | Director | 29 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Morbus Medicines Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Freedom Tieup Private Limited | ₹8.15 Lakh (FY 2023) | 12.0% | Varanasi, Uttar Pradesh, India | |||
| Pridesy Tradex Private Limited | ₹8.15 Lakh (FY 2021) | Patna, Bihar, India | ||||
| Bhagsu Brands Private Limited | ₹8.15 Lakh (FY 2024) | -27.0% | Kangra, Himachal Pradesh, India | |||
| Baheti Bullish Private Limited | ₹8.15 Lakh (FY 2024) | 382.0% | Surat, Gujarat, India | |||
| Dharapuram Pudhur Silk Handloom Weavers Producer Company Limited | ₹8.15 Lakh (FY 2025) | -61.0% | Omalur, Tamil Nadu, India | |||
| Morbus Medicines Private Limitedthis company | ₹8.15 Lakh (FY 2025) | -₹39,986 | -4.9% | -69.0% | Ahmedabad, Gujarat, India | |
| Prabhabiotech Private Limited | ₹8.15 Lakh (FY 2024) | 1.0% | Ahmedabad, Gujarat, India | |||
| Oaken Medicines Private Limited | ₹8.14 Lakh (FY 2016) | 222.0% | Indore, Madhya Pradesh, India | |||
| Renisha Impex Private Limited | ₹8.14 Lakh (FY 2024) | 700.0% | Mumbai, Maharashtra, India | |||
| Sri Nagarjuna Seeds Pvt Ltd | ₹8.14 Lakh (FY 2022) | Hyderabad, Telangana, India | ||||
| Eneff Powercom Private Limited | ₹8.14 Lakh (FY 2024) | -44.0% | New Delhi, Delhi, India |
To see the full peer comparison of Morbus Medicines Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Morbus Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Morbus Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Morbus Medicines Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Morbus Medicines Private Limited has 6 board changes on record since 2021: 3 appointments and 3 cessations. The latest: Pradhuman Singh Mahendra Singh Rathore ceased to be Additional Director on 24 Feb 2023.
Frequently asked questions
Morbus Medicines is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2021 (5+ years old) and is registered under CIN U51909GJ2021PTC125976.
Morbus Medicines has 3 current directors:
- Saurabh Hareshbhai Aacharya - Director
- Saumin Prakashbhai Shah - Director
- Yogesh Purshottam Harwani - Director
The latest financial statements of Morbus Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Morbus Medicines is U51909GJ2021PTC125976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Morbus Medicines was incorporated on 29 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Morbus Medicines by revenue are Freedom Tieup Private Limited, Pridesy Tradex Private Limited, Bhagsu Brands Private Limited, Baheti Bullish Private Limited, Dharapuram Pudhur Silk Handloom Weavers Producer Company Limited and 5 more, all in the same principal business activity (wholesale trading).
Pradhuman Singh Mahendra Singh Rathore ceased to be Additional Director on 24 Feb 2023. Shrey Prakash Shah ceased to be Additional Director on 24 Feb 2023. Monika Pragneshkumar Haswar ceased to be Director on 01 Nov 2022. Morbus Medicines has 6 board changes on record in total.
Yes, Morbus Medicines is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0113228).
The registered office of Morbus Medicines is at Shop No 311 Avani Icon Haridarshan Cross Road Naroda, Ahmedabad, Gujarat, India – 382330.
Morbus Medicines operates in the pharma industry, in the drug formulation and development segment.
Morbus Medicines can be reached at its registered office: Shop No 311 Avani Icon Haridarshan Cross Road Naroda, Ahmedabad, Gujarat, India – 382330.

